173 related articles for article (PubMed ID: 21430372)
1. Statins for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
Zhang T; Shen LH; Hu LH; He B
Am J Nephrol; 2011; 33(4):344-51. PubMed ID: 21430372
[TBL] [Abstract][Full Text] [Related]
2. Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials.
Liu YH; Liu Y; Duan CY; Tan N; Chen JY; Zhou YL; Li LW; He PC
J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):181-92. PubMed ID: 25193735
[TBL] [Abstract][Full Text] [Related]
3. Short-term, high-dose statins in the prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
Zhou Y; Yuan WJ; Zhu N; Wang L
Clin Nephrol; 2011 Dec; 76(6):475-83. PubMed ID: 22105451
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: A meta-analysis of 15 randomized controlled trials.
Liang M; Yang S; Fu N
Medicine (Baltimore); 2017 Jul; 96(27):e7384. PubMed ID: 28682890
[TBL] [Abstract][Full Text] [Related]
5. High-dose statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis.
Zhang BC; Li WM; Xu YW
Can J Cardiol; 2011; 27(6):851-8. PubMed ID: 21944277
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of short-term moderate or high-dose statin therapy for the prevention of contrast-induced nephropathy in high-risk patients with chronic kidney disease: systematic review and meta-analysis.
Zhou YL; Chen LQ; Du XG
Clinics (Sao Paulo); 2021; 76():e1876. PubMed ID: 33787670
[TBL] [Abstract][Full Text] [Related]
7. [The effects of short-term high-dose statins on the prevention of contrast-induced nephropathy in patients undertaking coronary angiography: a systematic review and meta-analysis].
Zhou Y; Yuan WJ
Zhonghua Nei Ke Za Zhi; 2011 Nov; 50(11):942-6. PubMed ID: 22333127
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials.
Li Y; Liu Y; Fu L; Mei C; Dai B
PLoS One; 2012; 7(4):e34450. PubMed ID: 22511942
[TBL] [Abstract][Full Text] [Related]
9. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
[TBL] [Abstract][Full Text] [Related]
10. 3-Hydroxy-3-methylglutaryl-CoA reductase enzyme inhibitors for prevention of contrast-induced nephropathy: a meta-analysis of prospective randomized controlled studies.
Briasoulis A; Mallikethi-Reddy S; Sharma S; Briasouli AA; Afonso L
Am J Ther; 2015; 22(6):e158-66. PubMed ID: 25187093
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
Patti G; Nusca A; Chello M; Pasceri V; D'Ambrosio A; Vetrovec GW; Di Sciascio G
Am J Cardiol; 2008 Feb; 101(3):279-85. PubMed ID: 18237585
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trials.
Zhang L; Zhang L; Lu Y; Wu B; Zhang S; Jiang H; Ge J; Chen H
Int J Clin Pract; 2011 May; 65(5):624-30. PubMed ID: 21489086
[TBL] [Abstract][Full Text] [Related]
13. Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
Bagshaw SM; Ghali WA
Arch Intern Med; 2005 May; 165(10):1087-93. PubMed ID: 15911721
[TBL] [Abstract][Full Text] [Related]
14. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention.
Kandula P; Shah R; Singh N; Markwell SJ; Bhensdadia N; Navaneethan SD
Nephrology (Carlton); 2010 Mar; 15(2):165-70. PubMed ID: 20470274
[TBL] [Abstract][Full Text] [Related]
15. Effect of statins in preventing contrast-induced nephropathy: an updated meta-analysis.
Xie H; Ye Y; Shan G; Zhang S; Fang Q; Yang D; Zeng Y
Coron Artery Dis; 2014 Nov; 25(7):565-74. PubMed ID: 25036858
[TBL] [Abstract][Full Text] [Related]
16. Contrast-induced nephropathy: do statins offer protection?
Sadat U
Curr Opin Cardiol; 2011 Jul; 26(4):334-7. PubMed ID: 21537166
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials.
Li H; Wang C; Liu C; Li R; Zou M; Cheng G
Am J Cardiovasc Drugs; 2016 Jun; 16(3):201-19. PubMed ID: 26899537
[TBL] [Abstract][Full Text] [Related]
18. A network meta-analysis on randomized trials focusing on the preventive effect of statins on contrast-induced nephropathy.
Peruzzi M; De Luca L; Thomsen HS; Romagnoli E; D'Ascenzo F; Mancone M; Sardella G; Lucisano L; Abbate A; Frati G; Biondi-Zoccai G
Biomed Res Int; 2014; 2014():213239. PubMed ID: 25276771
[TBL] [Abstract][Full Text] [Related]
19. Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.
Chanin JM; Yang DC; Haider MA; Swaminathan RV; Kim LK; Charitakis K; Tanoue M; Minutello RM; Gade CL; Singh HS; Bergman G; Wong SC; Feldman DN
J Invasive Cardiol; 2015 Nov; 27(11):490-6. PubMed ID: 25999136
[TBL] [Abstract][Full Text] [Related]
20. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions.
Khanal S; Attallah N; Smith DE; Kline-Rogers E; Share D; O'Donnell MJ; Moscucci M
Am J Med; 2005 Aug; 118(8):843-9. PubMed ID: 16084176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]